Form D — PharmaCyte Biotech, Inc.
0001683168-25-006676 · filed 2025-09-04
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $7,000,000
- Total sold
- $7,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- PharmaCyte Biotech, Inc.
- CIK
- 1157075
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 3960 HOWARD HUGHES PARKWAY
LAS VEGAS, NV 89169 - Phone
- (917) 595.2850
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joshua N. Silverman · Executive OfficerLAS VEGAS, NV Find on LinkedIn ↗
-
Carlos Trujillo · Executive OfficerLAS VEGAS, NV Find on LinkedIn ↗
-
Michael M. Abecassis · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Robert Weinstein · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Walker R. Wayne · DirectorLAS VEGAS, NV Find on LinkedIn ↗
-
Jonathan L. Schechter · DirectorLAS VEGAS, NV Find on LinkedIn ↗
View original on SEC EDGAR.